Internalization of non-clustered desmoglein 1 without depletion of desmoglein 1 from adhesion complexes in an experimental model of the autoimmune disease pemphigus foliaceus

International Journal of Immunopathology and Pharmacology

Volumn 20, Issue 2, 2007, Pages 355-361

  Lanza, A ^a   De Rosa, A ^a   Femiano, F ^a   Annese, P ^a   Ruocco, E ^a   Gombos, F ^a   Lanza, M ^a   Cirillo, Nicola ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Apoptosis; Desmoglein 1; Desmosome; Keratinocytes; Pemphigus

Indexed keywords

DESMOGLEIN 1; DESMOGLEIN 1 ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL ADHESION; CELL DISRUPTION; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DESMOSOME; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; PEMPHIGUS FOLIACEUS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; PROTEIN TRANSPORT;

EID: 34547118320     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200702000216     Document Type: Article

References (23)

1. Payne A.S., Y. Hanakawa, M. Amagai and J.R. Stanley. 2004. Desmosomes and disease: pemphigus and bullous impetigo. Curr. Opin. Cell. Biol. 16:536.
2. Wolff K. and E. Schreiner. 1971. Ultrastructural localization of pemphigus autoantibodies within the epidermis. Nature 229:59.
3. Bystryn J.C. and J.L. Rudolph. 2005. Pemphigus. Lancet 366:61.
4. Amagai M., T. Hashimoto, K.J. Green, N. Shimizu and T. Nishikawa. 1995. Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus. J. Invest. Dermatol. 104:895.
5. Stanley J.R., M. Year, P. Hawley Nelson and S.I. Katz. 1982. Pemphigus antibodies identify a cell surface glycoprotein synthesized by human and mouse keratinocytes. J. Clin. Invest 70:281.
6. Sekiguchi M., Y. Futei, Y. Fujii, T. Iwasaki, T. Nishikawa and M. Amagai. 2001. Dominant autoimmune epitopes recognized by pemphigus antibodies map to the N-terminal adhesive region of desmogleins. J. Immunol. 167:5439.
7. Gomi H., A. Kawada, M. Amagai and I. Matsuo. 1999. Pemphigus eryhtematosus: detection of anti-desmoglein 1 antibodies by ELISA. Dermatology 199:188.
8. Garrod D.R., A.J. Merritt and Z. Nie. 2002. Desmosomal cadherins. Curr. Opin. Cell. Biol. 14: 537.
9. Mahoney M.G., Z. Wang, K. Rothenberger, P.J. Koch, M. Amagai and J.R. Stanley. 1999. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J. Clin. Invest. 103:461.
10. Lanza A., N. Cirillo, F. Femiano and F. Gombos. 2006. How does acantholysis occur in pemphigus vulgaris: a critical review. J. Cutan. Pathol. 33:401.
11. Amerian M.L. and A.R. Ahmed. 1985. Pemphigus erythematosus Senear-Usher syndrome. Int. J. Dermatol. 24:16.
12. Karlhofer F.M., T. Hashimoto, K. Slupetzky, M. Kiss, Y. Liu, M. Amagai, F. Pieczkowski, D. Foedinger, R. Kirnbauer and G. Stingl. 2003. 230-kDa and 190-kDa proteins in addition to desmoglein 1 as immunological targets in a subset of pemphigus foliaceus with a combined cell-surface and base membrane zone immune staining pattern. Exp. Dermatol. 12:646.
13. Boukamp P., R.T. Petrussevska, D. Breitkreutz, J. Hornung, A. Markham and N.E. Fusenig. 1988. Normal keratinization in a spontaneously immortalized human keratinocyte cell line. J. Cell. Biol. 106:761.
14. Aoyama Y. and Y. Kitajima. 1999. Pemphigus vulgaris-IgG causes a rapid depletion of desmoglein 3 (Dsg3) from the Triton X-100 soluble pools, leading to the formation of Dsg3-depleted desmosomes in a human squamous carcinoma cell line, DJM-1 cells. J. Invest. Dermatol. 112:67.
15. Lanza A., F. Femiano, A. De Rosa, M. Cammarota, M. Lanza and N. Cirillo. 2006. The N-terminal fraction of desmoglein 3 encompassing its immunodominant domain is present in human serum: implications for pemphigus vulgaris autoimmunity. Int. J. Immunopathol. Pharmacol. 19:31.
16. Pasdar M. and W.J. Nelson. 1989. Regulation of desmosome assembly in epithelial cells: kinetics of synthesis, transport, and stabilization of desmoglein I, a major protein of the membrane core domain. J. Cell. Biol. 109:163.
17. Cirillo N., F. Femiano, F. Gombos and A. Lanza. 2006. Serum from pemphigus vulgaris reduces desmoglein 3 half-life and perturbs its de novo assembly to desmosomal sites in cultured keratinocytes. FEBS Lett. 580:3276.
18. Calkins C.C., S.V. Setzer, J.M. Jennings, S. Summers, K. Tsunoda, M. Amagai and A.P. Kowalczyk. 2006. Desmoglein endocytosis and desmosome disassembly are coordinated responses to pemphigus autoantibodies. J. Biol. Chem. 281: 7623.
19. Cirillo N., F. Femiano, F. Gombos and A. Lanza. 2007. Metalloproteinase 9 is the outer executioner of desmoglein 3 in apoptotic keratinocytes. Oral Dis. 13:341
20. Lozano C., J.L. Torres, L. Julia, A. Jimenez, J.J. Centelles and M. Cascante. 2005. Effect of new antioxidant cysteinyl-flavanol conjugates on skin cancer cells. FEBS Lett. 579:4219.
21. Pelacho B., C. Natal, A. Espana, I. Sanchez-Carpintero, M.J. Iraburu and M.J. Lopez-Zabalza. 2004. Pemphigus vulgaris autoantibodies induce apoptosis in HaCaT keratinocytes. FEBS Lett. 566:6.
22. Waschke J., P. Bruggeman, W. Baumgartner, D. Zillikens and D. Drenckhahn. 2005. Pemphigus foliaceus IgG causes dissociation of desmoglein 1-containing junctions without blocking desmoglein 1 transinteraction. J. Clin. Invest. 115:3157.
23. Cirillo N. and A. Lanza. 2006. Pemphigus acantholysis and steric hindrance: an unsolved equation. J. Clin. Invest. http://www.jci.org/cgi/ eletters/115/11/3157